-
1Image
المؤلفون: Alcibiade Athanasiou (4325797), Pierre Tennstedt (4325800), Anja Wittig (8856431), Ramy Huber (8856434), Oliver Straub (11689839), Ralph Schiess (727375), Thomas Steuber (2852741)
مصطلحات موضوعية: Medicine, Cell Biology, Biotechnology, Immunology, Cancer, Hematology, Space Science, Mathematical Sciences not elsewhere classified, tumor marker concentrations, new biomarker combination, also significantly associated, 20 8211, standard clinical parameters, proposed marker combination, clinical grade group, 6 %) subsets, matrix metalloprotease 9, risk patient subset, serum using immunoassays, predicting biochemical recurrence, 0 8211, prostate risk assessment, meier analysis showed, 9 %), gg, prostate cancer patients, biochemical recurrence, prostate cancer, serum samples, proposed model
-
2Image
المؤلفون: Alcibiade Athanasiou (4325797), Pierre Tennstedt (4325800), Anja Wittig (8856431), Ramy Huber (8856434), Oliver Straub (11689839), Ralph Schiess (727375), Thomas Steuber (2852741)
مصطلحات موضوعية: Medicine, Cell Biology, Biotechnology, Immunology, Cancer, Hematology, Space Science, Mathematical Sciences not elsewhere classified, tumor marker concentrations, new biomarker combination, also significantly associated, 20 8211, standard clinical parameters, proposed marker combination, clinical grade group, 6 %) subsets, matrix metalloprotease 9, risk patient subset, serum using immunoassays, predicting biochemical recurrence, 0 8211, prostate risk assessment, meier analysis showed, 9 %), gg, prostate cancer patients, biochemical recurrence, prostate cancer, serum samples, proposed model
-
3Image
المؤلفون: Alcibiade Athanasiou (4325797), Pierre Tennstedt (4325800), Anja Wittig (8856431), Ramy Huber (8856434), Oliver Straub (11689839), Ralph Schiess (727375), Thomas Steuber (2852741)
مصطلحات موضوعية: Medicine, Cell Biology, Biotechnology, Immunology, Cancer, Hematology, Space Science, Mathematical Sciences not elsewhere classified, tumor marker concentrations, new biomarker combination, also significantly associated, 20 8211, standard clinical parameters, proposed marker combination, clinical grade group, 6 %) subsets, matrix metalloprotease 9, risk patient subset, serum using immunoassays, predicting biochemical recurrence, 0 8211, prostate risk assessment, meier analysis showed, 9 %), gg, prostate cancer patients, biochemical recurrence, prostate cancer, serum samples, proposed model
-
4Image
المؤلفون: Alcibiade Athanasiou (4325797), Pierre Tennstedt (4325800), Anja Wittig (8856431), Ramy Huber (8856434), Oliver Straub (11689839), Ralph Schiess (727375), Thomas Steuber (2852741)
مصطلحات موضوعية: Medicine, Cell Biology, Biotechnology, Immunology, Cancer, Hematology, Space Science, Mathematical Sciences not elsewhere classified, tumor marker concentrations, new biomarker combination, also significantly associated, 20 8211, standard clinical parameters, proposed marker combination, clinical grade group, 6 %) subsets, matrix metalloprotease 9, risk patient subset, serum using immunoassays, predicting biochemical recurrence, 0 8211, prostate risk assessment, meier analysis showed, 9 %), gg, prostate cancer patients, biochemical recurrence, prostate cancer, serum samples, proposed model
-
5Image
المؤلفون: Alcibiade Athanasiou (4325797), Pierre Tennstedt (4325800), Anja Wittig (8856431), Ramy Huber (8856434), Oliver Straub (11689839), Ralph Schiess (727375), Thomas Steuber (2852741)
مصطلحات موضوعية: Medicine, Cell Biology, Biotechnology, Immunology, Cancer, Hematology, Space Science, Mathematical Sciences not elsewhere classified, tumor marker concentrations, new biomarker combination, also significantly associated, 20 8211, standard clinical parameters, proposed marker combination, clinical grade group, 6 %) subsets, matrix metalloprotease 9, risk patient subset, serum using immunoassays, predicting biochemical recurrence, 0 8211, prostate risk assessment, meier analysis showed, 9 %), gg, prostate cancer patients, biochemical recurrence, prostate cancer, serum samples, proposed model
-
6Image
المؤلفون: Alcibiade Athanasiou (4325797), Pierre Tennstedt (4325800), Anja Wittig (8856431), Ramy Huber (8856434), Oliver Straub (11689839), Ralph Schiess (727375), Thomas Steuber (2852741)
مصطلحات موضوعية: Medicine, Cell Biology, Biotechnology, Immunology, Cancer, Hematology, Space Science, Mathematical Sciences not elsewhere classified, tumor marker concentrations, new biomarker combination, also significantly associated, 20 8211, standard clinical parameters, proposed marker combination, clinical grade group, 6 %) subsets, matrix metalloprotease 9, risk patient subset, serum using immunoassays, predicting biochemical recurrence, 0 8211, prostate risk assessment, meier analysis showed, 9 %), gg, prostate cancer patients, biochemical recurrence, prostate cancer, serum samples, proposed model
-
7Image
المؤلفون: Alcibiade Athanasiou (4325797), Pierre Tennstedt (4325800), Anja Wittig (8856431), Ramy Huber (8856434), Oliver Straub (11689839), Ralph Schiess (727375), Thomas Steuber (2852741)
مصطلحات موضوعية: Medicine, Cell Biology, Biotechnology, Immunology, Cancer, Hematology, Space Science, Mathematical Sciences not elsewhere classified, tumor marker concentrations, new biomarker combination, also significantly associated, 20 8211, standard clinical parameters, proposed marker combination, clinical grade group, 6 %) subsets, matrix metalloprotease 9, risk patient subset, serum using immunoassays, predicting biochemical recurrence, 0 8211, prostate risk assessment, meier analysis showed, 9 %), gg, prostate cancer patients, biochemical recurrence, prostate cancer, serum samples, proposed model
-
8
المؤلفون: Alcibiade Athanasiou (4325797), Pierre Tennstedt (4325800), Anja Wittig (8856431), Ramy Huber (8856434), Oliver Straub (11689839), Ralph Schiess (727375), Thomas Steuber (2852741)
مصطلحات موضوعية: Medicine, Cell Biology, Biotechnology, Immunology, Cancer, Hematology, Space Science, Mathematical Sciences not elsewhere classified, tumor marker concentrations, new biomarker combination, also significantly associated, 20 8211, standard clinical parameters, proposed marker combination, clinical grade group, 6 %) subsets, matrix metalloprotease 9, risk patient subset, serum using immunoassays, predicting biochemical recurrence, 0 8211, prostate risk assessment, meier analysis showed, 9 %), gg, prostate cancer patients, biochemical recurrence, prostate cancer, serum samples, proposed model
-
9
المؤلفون: Alcibiade Athanasiou (4325797), Pierre Tennstedt (4325800), Anja Wittig (8856431), Ramy Huber (8856434), Oliver Straub (11689839), Ralph Schiess (727375), Thomas Steuber (2852741)
مصطلحات موضوعية: Medicine, Cell Biology, Biotechnology, Immunology, Cancer, Hematology, Space Science, Mathematical Sciences not elsewhere classified, tumor marker concentrations, new biomarker combination, also significantly associated, 20 8211, standard clinical parameters, proposed marker combination, clinical grade group, 6 %) subsets, matrix metalloprotease 9, risk patient subset, serum using immunoassays, predicting biochemical recurrence, 0 8211, prostate risk assessment, meier analysis showed, 9 %), gg, prostate cancer patients, biochemical recurrence, prostate cancer, serum samples, proposed model
-
10
المؤلفون: Alcibiade Athanasiou (4325797), Pierre Tennstedt (4325800), Anja Wittig (8856431), Ramy Huber (8856434), Oliver Straub (11689839), Ralph Schiess (727375), Thomas Steuber (2852741)
مصطلحات موضوعية: Medicine, Cell Biology, Biotechnology, Immunology, Cancer, Hematology, Space Science, Mathematical Sciences not elsewhere classified, tumor marker concentrations, new biomarker combination, also significantly associated, 20 8211, standard clinical parameters, proposed marker combination, clinical grade group, 6 %) subsets, matrix metalloprotease 9, risk patient subset, serum using immunoassays, predicting biochemical recurrence, 0 8211, prostate risk assessment, meier analysis showed, 9 %), gg, prostate cancer patients, biochemical recurrence, prostate cancer, serum samples, proposed model